Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Quote "we are less than a year away" means next week, 2 weeks, a month, get the picture we are fast tracked to mass production
Quote "there are no major hurdle to complete" we're ready
MASS$$$$$$$$$$production$$$$$$$$$$$
http://www.foxbusiness.com/on-air/willis-report/videos#p/157870/v/3841659343001
PSID IS THE ONLY COMPANY DOD WORKED WITH , DHS INKED THE CONTRACT THRU ENSCO FOR DENSE DEPLOYMENT OF FIREFLY DX #2(10 MIN RESULTS), CDC AND FDA NEEDED TO GET ON THE BALL AND AUTHORIZED THE USE.
Dr Luciana Borio before congress stated quote"and In addition, we have used another regulatory mechanism, the emergency use authorization (EUA), to enable access to yet another unapproved product. Under the EUA authority, we authorized the use of an Ebola diagnostic test that was under development by the Department of Defense (DOD), and those tests are now being deployed to the Laboratory Response Network of the Centers for Disease Control and Prevention (CDC) to improve the nation's capability to diagnose or rule out Ebola in patients who may present with symptoms in conjunction with epidemiologic risk factors consistent with Ebola at our clinics".
“We call it a laboratory in the palm of your hand,” Probst said. “It will do the whole testing process that you do in a lab to detect some type of organism in 10 to 15 minutes, compared to several hours in a lab.”
Training to run the tests should be a simple process for airport personnel or field workers, Probst said. “We’ve taken the guesswork out of it and the person running the test doesn’t need to be a programmer or even a medical person.” A small blood sample can be taken with a finger prick, while a swab can be used to swab the nose or the mouth of a patient.
On the technology side, PositiveID has designed the system to allow different test programs to be encoded on an RFID chip inside the one-use cartridges. The reagents and other fluids needed to conduct the test are also inside the cartridge, and those test results are transmitted to the laptop device optically.
Once transmitted to the larger Firefly device, the data is further interpreted and can be sent to a smartphone or other device via Bluetooth or Wi-Fi, with the data eventually stored in a cloud-based system easily accessible by multiple parties. The data can also be read on an LED display.
Firefly runs on a proprietary, open-source operating system built with C, C++ and HTML tools, Probst said. A separate battery charger can re-charge the device’s Lithium-Ion battery.
Much of the research on Firefly actually began a decade ago and cost $35 million in funds from the U.S. Department of Homeland Security
WHY PSID WON$$$$$ The WHO has urged all nations, including the U.S., to be prepared to detect, investigate and manage Ebola cases, including providing access to a qualified diagnostic lab for Ebola detection at international airports and major land crossing points.
PSID FIREFLY DX “The largest application will be for diseases, including flu and Ebola
.
Firefly can also be used to detect radiation poisoning from a blood sample to determine the exact level of radiation exposure, which can useful for patients undergoing cancer treatment as well as astronauts in outer space, Probst said.
“The largest application will be for diseases, including flu and Ebola or a pathogen that comes into the country intentionally or unintentionally,” Probst said. It could even be used to test cows for Mad Cow disease, he said.
Probst was trained originally as a biologist, but also holds an MBA and manages the business side of PositiveID, which employs just 10 full-time staff. Manufacturing and other processes are outsourced.
Work on Firefly is obviously timely, given the current Ebola outbreak and likely outbreaks in the future.
Probst said he thinks other companies might be developing mobile Ebola testing devices, but placed PositiveID on the “cutting edge” of development.
A Denver company, Corgenix Medical, is also working on a rapid diagnostic test kit for Ebola, but the work is in early stages and could last another three years, according to a statement released Monday. It isn’t clear whether the Corgenix test kit would be used as a mobile device like the Firefly, or in some other form like a home test kit. Corgenix didn’t respond to a request to comment.
Corgenix is working with the Viral Hemorrhagic Fever Consortium headed by Tulane University to use a $2.9 million National Institutes of Health grant to accelerate efforts to develop rapid result diagnostic kits to be ready by the time of the next Ebola outbreak. L
PSID Fast Tracked$$$$$$$$
Psid of Only 2 companies that are doing On point test for ebola
.
Corgenix is the other company but did not get this go ahead PSID IS THE ONLY COMPANY DOD WORKED WITH , DHS INKED THE CONTRACT THRU ENSCO FOR DENSE DEPLOYMENT OF FIREFLY DX #2(10 MIN RESULTS), CDC AND FDA NEEDED TO GET ON THE BALL AND AUTHORIZED THE USE.
Dr Luciana Borio before congress and In addition, we have used another regulatory mechanism, the emergency use authorization (EUA), to enable access to yet another unapproved product. Under the EUA authority, we authorized the use of an Ebola diagnostic test that was under development by the Department of Defense (DOD), and those tests are now being deployed to the Laboratory Response Network of the Centers for Disease Control and Prevention (CDC) to improve the nation's capability to diagnose or rule out Ebola in patients who may present with symptoms in conjunction with epidemiologic risk factors consistent with Ebola at our clinics
DD NEWS Right now on CNN testimony given by Dr. Luciana Borio
In addition, we have used another regulatory mechanism, the emergency use authorization (EUA), to enable access to yet another unapproved product. Under the EUA authority, we authorized the use of an Ebola diagnostic test that was under development by the Department of Defense (DOD), and those tests are now being deployed to the Laboratory Response Network of the Centers for Disease Control and Prevention (CDC) to improve the nation's capability to diagnose or rule out Ebola in patients who may present with symptoms in conjunction with epidemiologic risk factors consistent with Ebola at our clinics.
VERY INTERESTING COMMENTS MADE ABOUT CONTENT PROVIDERS..HBO STREAM
http://www.foxbusiness.com/on-air/money-with-melissa-francis/index.html#/v/3840995455001
60 DAYS TO COUNTDOWN PSID$$$$http://www.foxbusiness.com/on-air/money-with-melissa-francis/index.html
$$$$FIREFLY DX new and improved mass production DHS fast tracked LET"S STOP THE SPREAD OF EBOLA $$$$$$$$$$$
LET's SQUEEEEEEEEEZ THEM SPREAD THIS OUT
LOCK UP YOUR SHARES THIS WILL BLOW DON"T GIVE IT TO THE SHORTS THEY"LL USE IT AGAINST YOU.
SHORT SQUEEZE
$$$$$GOING out of penny land folks
MORE EXPLOSIVE NEWS COMING, ENSCO will design and model a smart system that integrates data from densely deployed, low-cost, environmental monitoring sensors with best of breed confirmation technology provided by its partner PositiveID. ENSCO will add unique event processing, false alarm reduction, and source location capabilities into an open and flexible architecture to illustrate how this system meets DHS’s ambitious, high performance and low cost challenge.
"Less than a year" "YOU'RE PRODUCING IN MASS" WOW $$$$$$$$$$$$$$$$$$$
NEWS$$$$$NEXT GEN FIREFLY DX updates ebola test results faster to 10 mins $$$$$$$$$$$$$$$$$$$$$$$$$$$
After a comment board message CNN talking about early detection of ebola and highlights the effectiveness of going this way to contain the virus mentions 15-20 mins. testing (FIREFLY DX IMO)
PSID in Contact EBOLA is FAST TRACKED
ENSCO, Inc. Announces New Contract to Assess Bio Threats
Falls Church, Va., October 10, 2014 – ENSCO recently won the first phase of an innovative new contract with the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate’s SenseNet program to research and develop a system using low-cost environmental monitoring sensors to address the Bio threat. This program supports DHS’s mission, which includes preventing, detecting, responding to, and recovering from intentional or accidental introduction of aerosolized biological and chemical agents.
Under this first phase contract, ENSCO will design and model a smart system that integrates data from densely deployed, low-cost, environmental monitoring sensors with best of breed confirmation technology provided by its partner PositiveID. ENSCO will add unique event processing, false alarm reduction, and source location capabilities into an open and flexible architecture to illustrate how this system meets DHS’s ambitious, high performance and low cost challenge.
“We are especially proud to win this contract with the DHS S&T Directorate because it is a new customer for ENSCO and one we hope to establish a long-term relationship with,” said Dr. Michael Glass, Vice President, National Security Solutions Division of ENSCO. “Further, it is the result of cross-division collaboration and combining capabilities from across the company to meet the unique needs of this important customer.”
About ENSCO, Inc.
ENSCO, Inc., and its wholly owned subsidiaries represent a $90 million technology enterprise, headquartered in the Washington, D.C., area. For more than 45 years, the ENSCO group of companies has been providing ingenious engineering, science and advanced technology solutions that guarantee mission success, safety and security to governments and private industries around the globe. ENSCO operates in the defense, transportation, aerospace and intelligence sectors. Field offices and subsidiaries, representatives and partnerships are located throughout the United States and around the world.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Top
HBO New partners Ultra Flix??????????????In 2015 @HBO will launch standalone HBO service in the US, will work with current partners & explore models with new partners
Seems Netflix in trouble
http://fortune.com/2014/10/15/time-warner-hbo-go-standalone/?xid=ob_rss
Due to rna sequence virus could go airborne http://video.foxnews.com/v/3840172448001/purdue-professor-says-ebola-primed-to-go-airborne/?intcmp=obnetwork#sp=show-clips
you sly evaded the question again name your solution
name your solution to stop ebola
Got more on the dip
NEW$$$$$$$$$ SOOOOONhttp://www.bioworld.com/content/fda-grants-emergency-use-authorization-ebola-assay-0
FDA grants emergency use authorization for Ebola assay
Share
By Mark McCarty, Medical Device Daily Washington Editor
The FDA granted emergency use authorization to the Department of Defense (DoD) for an assay to help contain the outbreak of Ebola in western Africa.
The DoD's Ebola Zaire Target 1 real-time polymerase chain reaction assay – one of the Taqman series of assays – can be run on several analyzers, including Indianapolis-based Roche Diagnostics' Lightcycler. However, the news has prompted the DoD to commence work on a rapid diagnostic using the Xmap analyzer co-developed with Luminex Corp., of Austin, Texas, indicating a strong interest on the part of the DoD in a high-capacity multiplexing system for containing this latest outbreak of Ebola.
The outbreak drove the U.S. Centers for Disease Control and Prevention to post a level 1 alert after health care providers in Nigeria diagnosed a patient with the disease. The outbreak has also sparked coverage of FDA's review of treatments for Ebola, but diagnostics makers are scrambling to leverage their assets, including PositiveID, of Delray Beach, Fla., which is touting the firm's handheld Firefly DX, another Taqman PCR system, as a potentially valuable tool in constraining the spread of Ebola.
The FDA's statement specifies that any diagnostics used in this authorization sample be only Trizol-inactivated whole blood or Trizol-inactivated plasma, limiting the EUA to "the use of the authorized EZ1 rRT-PCR assay on specified instruments by laboratories designated by DoD." Along with Roche's Lightcycler, the agency lists the JBAIDS system by Biofire Diagnostics, of Salt Lake City, Utah, and the Applied Biosystems 7500 by Life Technologies, brand of Thermo Fisher Scientific, of Carlsbad, Calif. The FDA statement does not say which DoD-designated labs feature the listed analyzers.
Luminex reported that the diagnostic division of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) was working with the firm on a rapid diagnostic for Ebola with the company's Xmap system, but Luminex added that its Magpix system "was recently deployed to Africa to support research efforts to control the current outbreak." The Magpix is the firm's desktop computer-sized analyzer system whereas xMap (multi-analyte profiling) technology consists of polystyrene microspheres that can be imaged by Magpix with light-emitting diodes to offer the kind of fast and compact testing system needed for communicable disease outbreaks such as the latest Ebola episode.
Amy Altman, VP for biodefense at Luminex, told Medical Device Daily, "we can multiplex up to 500 targets in a single reaction" with Magpix, remarking that many current systems based on real time chemistry have a multiplexing limit of about six-plex. "Some of the systems are a one-sample-per-hour system, where we have the capability of fast-processing 96 samples at a time up to 384 samples at a time," Altman said.
"USAMRIID has multiple systems of our hardware, and they were using them in Maryland to develop" tests in a biocontainment lab there, Altman said. "They took some of the instruments they had in Maryland and shipped them to Africa along with their assays and their personnel to do testing," she explained.
Altman said the EZ1 assay FDA has cleared for the EUA detects ribonucleic acids, but the assays USAMRIID and Luminex have been working on "are assays against the proteins on the viral surface, and they also have a set of assays that check for antibodies against Ebola." Thus even if the test generates no indicators of surface proteins, a finding of antibodies at least suggests exposure, giving medical staff in western Africa a clearer sense of the extent of the spread.
As for whether Luminex can turn out enough hardware to keep up with USAMRIID demand, Altman said, "we have enough [inventory and production capacity] that we can support whatever mission they have." She explained that because Luminex co-developed Xmap with the USAMRIID, the agency is entirely responsible at present for any premarket activities required by FDA where the Ebola predicament is concerned. //
Editor's note: Medical Device Daily is the news source of record for the high-tech medical technology industry. This business-focused intelligence service is the flagship publication of BioWorld's med-tech group. To learn more about how to subscribe to Medical Device Daily, please visit http://www.medicaldevicedaily.com/.
Published: BioWorld Today, August 8, 2014
FIRE FLY is the only chance for the human race to survive EBOLA must detect and contain no other method works
http://www.theguardian.com/world/2014/oct/09/ebola-david-miliband-warns-tipping-point
DHS FAST TRACT PSID FIRE FLY FOR Threat of EBOLA
http://smallcapvoice.com/blog/10-1-14-smallcapvoice-interview-with-positiveid-corporation-psid/
Major News SOOON ON FIREFLY rollout $$$$$$$More Ebola cases in U.S.
You should post Amazon FIN compare NTEK
You fail to mention the push back against their efforts
The plan to release "Crouching Tiger, Hidden Dragon: The Green Legend" on Netflix in all of its markets in August on the same day the movie appears in select IMAX theaters has also raised the hackles of some theater owners. Chains AMC Entertainment, Regal Entertainment Group and Cinemark Holdings Inc are refusing to show the film.
It remains to be seen whether such opposition will deter other filmmakers from playing ball with Netflix in the future.
They are stepping on some toes
ULTRAFLIX is the lead and the wind is in the sails
Net Flix Is Waking up
“We’re very excited to leverage our investment in 4K Ultra HD content. UltraFlix will be front and center at these demonstrations. No matter what 4K Ultra HD brand television consumers buy, they will be able to access the UltraFlix library for the biggest and best 4K Ultra HD library available through the embedded Smart TV version or by connecting the Nuvola NP-1 4K Ultra HD streaming set top box.”
Netflix feeling the heat from ULTRAFLIX
http://finance.yahoo.com/news/netflix-movie-push-aims-freshen-165121692.html
Read into this you'll get the answer to your question
revenue from pure OTT services like NanoTech’s UltraFlix is estimated to grow from $14 billion in 2013 to $37 billion by 2017.
2013 4k tv did not get it's running start but 2015 it will.
Any guesses how may viewers ULTRAFLIX will have subscribe http://usatoday30.usatoday.com/life/television/news/2004-02-24-nielsens-analysis_x.htm
seen by 10.6 million viewers, smashing a Sex-record 7.7 million set on Sept. 14. In HBO history, the show ranks second only to The Sopranos.
This Is Junk as Some here has claim NTEK contents to be WOW wonder what in 4K content Netflix has any guesses